Total Funding
26
57
Total FundingPost-IPO Equity raised
Growth Score
-33 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
279018
Beleave Inc. is a biotech company and Beleave's wholly-owned subsidiary Beleave Kannabis Corp
- Andrew Wnek: CEOPast Role: Canadian Cancer Society, Interim CFO
- Roger Ferreira: Chief Science Officer, Director
About the Company
Their passion for what we do comes from a place of compassion. With determination and commitment, we believe that when used properly, medicinal cannabis has the potential for treatment of symptoms associated with a variety of disorders.
